Hodgkin lymphoma who is at risk

But a family link is still uncommon — most people with HL do not have a family history of it. It might be because family members have similar childhood exposures to certain infections such as Epstein-Barr virus , because they share inherited gene changes that make them more likely to get HL, or some combination of these factors.

People who take medicines to suppress the immune system after an organ transplant and people with auto-immune diseases are also at higher than normal risk for HL. It tends to occur most often in people between the ages of years old and again in those over 55 years old. People of European descent also have a higher risk for Hodgkin lymphoma than other ethnic groups. Adult Hodgkin lymphoma treatment PDQ —patient version. National Cancer Institute website.

Accessed January 28, Hodgkin lymphoma. Hodgkin lymphoma HL. Hodgkin lymphoma risk factors. American Cancer Society website.

Exceptional Nurses Winchester Hospital was the first community hospital in the state to achieve Magnet designation, recognition for nursing excellence. Supporting Our Community Our tremendous staff gives back to our community by coordinating free health screenings, educational programs, and food drives.

What Our Patients are Saying A leading indicator of our success is the feedback we get from our patients. Home Health Library. Other factors that may increase your chance of Hodgkin lymphoma include: Previous mononucleosis mono infection —Mono is caused by the Epstein-Barr virus EBV which remains in the body even after symptoms have passed.

However, many people have EBV and very few develop lymphoma. Hodgkin lymphoma. Maurer MJ, et al. Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy. Journal of Clinical Oncology. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. Laurent C, et al. Impact of expert pathologic review of lymphoma diagnosis: Study of patients from the French Lymphopath Network.

Ansell SM, et al. Pd-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. New England Journal of Medicine. Johnston PB, et al. The Lancet Haematology. Accessed July 24, Mayo Clinic first in U. What you need to know about Hodgkin lymphoma. Accessed June 12, Thompson CA expert opinion. Nowakowski GS, et al.

Rochester, Minn. Common side effects of radiation therapy. American Cancer Society. Gender: Men have a slightly greater chance of developing the disease than women. Age: Adults in their 20s and early 30s and those over age 55 are at an increased risk for developing Hodgkin lymphoma. Family history: Having a parent or sibling with the disease may increase the risk. However, the American Cancer Society reports that only 5 percent of cases are found to have a family link.

Learn more about genetic testing. Geography: Hodgkin lymphoma is most common in North America and northern Europe.